American Society of Hematology Annual Meeting

Orlando, FL

2019

Principal Investigators:  Susan Parsons and Andy Evens

Andrew Evens, DO

Rutgers Cancer Institute of New Jersey

Co-Principal Investigator, Adult Oncology

Susan Parsons, MD, MRP

Tufts Medical Center

Co-Principal Investigator, Pediatric/AYA Oncology

Ranjana Advani, MD

Stanford U. School of Medicine

Adult Oncology

Nickhill Bhakta, MD, MPH

St. Jude Children's Research Hospital

Decision Science, Pediatric Oncology

Sharon Castellino, MD, MSc

ADD Aflac Cancer and Blood Disorder Center

Pediatric Oncology

Joshua T. Cohen, PhD

Tufts Medical Center

Decision Science, Health Economic

Massimo Federico, MD

Association Angela Serra for Cancer Research, FIL (Fondazione Italiana Linfomi)

Adult Oncology

Christopher Flowers, MD, MS

MD Anderson

Adult Oncology

Debra Friedman, MD, MS

Vanderbilt U. Medical Center

Pediatric Oncology

Theresa Hahn, PhD

Roswell Park Comprehensive Cancer Center

Epidemiology/Transplant & Cellular Therapy

Tara Henderson, MD, MPH

U. of Chicago

Pediatric Oncology

Bradford Hoppe, MD, MPH

Mayo Clinic

Radiation Oncology

Martin Hutchings, MD, PhD

Rigshospitalet, EORTC (European Organisation for Research and Treatment of Cancer)

Adult Oncology, Imaging

Frank Keller, MD

Emory U. School of Medicine, Children's Healthcare of Atlanta

Pediatric Oncology

Anita Kumar, MD, MSCE

Tufts Medical Center

Adult Hematology/Oncology

Michael P. Link, MD

Stanford U. School of Medicine

Pediatric Oncology

Matthew Maurer, DMSc

Mayo Clinic

Statistics/Epidemiology

Lindsay Morton, PhD

National Cancer Institute

Epidemiology

Stephen Opat

Lymphoma and Related Diseases Registry, Monash University, Melbourne

Adult Oncology

Les Robison, PhD

St. Jude Children's Research Hospital

Statistics/Epidemiology

Cindy Schwartz, MD, MPH

Medical College of Wisconsin

Pediatric Oncology

Christian Steidl, MD

British Columbia Cancer

Biology

Judith Trotman, FRACP, FRCPA

Concord Repatriation General Hospital and University of Sydney

Adult Haematology

Samuel Volchenboum, MD, PhD

U. of Chicago

Pediatric Oncology, Data Science

F. Lennie Wong, PhD

City of Hope

Statistics/Epidemiology

Berthe Aleman, MD, PhD

Netherlands Cancer Institute

Radiation Oncology

Sven Borchmann, MD

German Hodgkin Study Group University of Cologne, Germany

Adult Oncology

James Cerhan, MD, PhD

Mayo Clinic

Epidemiology

Peter Cole, MD

Rutgers Cancer Institute of New Jersey

Pediatric Oncology

Lizette Figueroa-Rivera, MA

The Leukemia & Lymphoma Society

Patient Advocacy

Catherine Fortpied, MSc

EORTC (European Organisation for Research and Treatment of Cancer)

Statistics/Epidemiology

Andrea Gallamini, MD

Lacassagne Cancer Center, LYSA (Lymphoma Study Association)

Adult Oncology-Hematology, Imaging

Eliza Hawkes, DMedSc

Lymphoma and Related Diseases Registry, Monash University, Melbourne

Adult Oncology

David Hodgson, MD, MPH, FRCPC

Princess Margaret Cancer Centre

Radiation Oncology and Late Effects

Peter Hoskin, MD, FRCP, FRCR

Mount Vernon Cancer Centre & U of Manchester

Radiation Oncology

Peter Johnson, MD, FRCP, FMedSci

U. of Southampton/Cancer Research UK

Adult Oncology

Kara Kelly, MD

Roswell Park Comprehensive Cancer Center

Pediatric Oncology

John Kuruvilla, MD, FRCPC

Princess Margaret Cancer Centre

Adult Oncology

Brian Link, MD

U. of Iowa

Adult Hematology

Zoe McQuilten

Lymphoma and Related Diseases Registry, Monash University, Melbourne

Adult Oncology

Jason Nelson, MPH

Tufts Medical Center

Decision Science

John Radford, MBChB

U. of Manchester

Adult Oncology

Angie Mae Rodday, PhD

Tufts Medical Center

Statistics/Epidemiology

David Scott, MBChB, PhD

British Columbia Cancer

Biology

David Straus, MD

Memorial Sloan Kettering Cancer Center

Adult Oncology

Jenica Upshaw, MD

Tufts Medical Center

Cardiology

Lorna Warwick

Lymphoma Coalition

Patient Advocacy

Erica Wood, MBBS

Lymphoma and Related Diseases Registry, Monash University, Melbourne

Adult Oncology

Marc Andre, MD

CHU UCL Namur, LYSA (Lymphoma Study Association)

Adult Oncology

Megan Cardoso, MD

Chelmsford Pediatrics/Stakeholder

Patient Advocacy

Chun Chao, PhD

Kaiser Permanente Southern California

Statistics/Epidemiology

Andreas Engert, MD

German Hodgkin Study Group

Adult Oncology

Jamie Flerlage, MD

St. Jude Children's Research Hospital

Pediatric Oncology

Jonathan Friedberg, MD, MMSc

U. of Rochester/Wilmot Cancer Institute

Adult Oncology

Meghan Gutierrez

Lymphoma Research Foundation

Patient Advocacy

Annette Hay, MBChB,FRCPath,FRCPC

Queen's University, Canadian Cancer Trials Group

Adult Hematology

Richard T. Hoppe, MD

Stanford U.

Radiation Oncology

Melissa Hudson, MD

St. Jude Children's Research Hospital

Pediatric Oncology

Gajan Kailainathan, MD

Concord Repatriation General Hospital and Faculty of Medicine and Health

Adult Oncology

Lale Kostakoglu Shields, MD, MPH

U. of Virginia

Medical Imaging

Sean Hua Lim, MBChB,PhD

U. of Southampton

Cancer Immunology, Hematology

Raymond Mailhot, MD, MPH

U. of Florida

Radiation Oncology

Ralph Meyer, MD, FRCP(C)

McMaster University and Cancer Care Ontario

Adult Hematology-Oncology

Andrea Ng, MD

Brigham & Women's Hospital/Harvard Medical School

Radiation Oncology and Late Effects

John Raemaekers, MD, PhD

EORTC (European Organisation for Research and Treatment of Cancer)

Adult Hematology

Kerry Savage, MD, MSc, FRCP(C)

British Columbia Cancer

Medical Oncology

Lena Specht, MD, DMSc

Rigshospitalet, EORTC , University of Copenhagen

Clinical Oncology

Carrie Thompson, MD

Mayo Clinic

Adult Hematology

Flora Van Leeuwen, PhD

Netherlands Cancer Institute

Epidemiology/Statistics/Late adverse treatment effects

John Wong, MD

Tufts Medical Center

Decision Science

Pier Luigi Zinzani, MD, PhD

Institute of Hematology, University of Bologna, FIL (Fondazione Italiana Linfomi)

Adult Hematology